Similarly, studies in animal models of MS (i.e., experimental autoimmune encephalomyelitis, EAE), have shown that IL-10 gene therapy has a beneficial effect on both motor and non-motor symptoms, including fatigue, anxiety and neuropathic pain [33]. This evidence concerns the gene IL10 and myeloid sarcoma.